![John Henderson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
John Henderson
Président chez
CYTOKINETICS, INCORPORATED
Fortune : 7 M $ au 30/06/2026
Profil
John Tannahill Henderson is Chairman at Cytokinetics, Inc. since 2022, with employment at the firm starting in 2009.
Former roles include Chairman at Asmacure Ltée; Independent Director at Myriad Genetics, Inc. in 2020; Non-Executive Director at Inveresk Research Group, Inc.; Independent Director at Myrexis, Inc. from 2011 to 2013; Vice President at Pfizer Pharmaceuticals, Inc.; President at Futurepharm LLC; Chief Development Officer at NeuroVia, Inc.; and VP-Europe, US & International Pharmaceuticals at Pfizer Inc. Education includes undergraduate and doctorate degrees from The University of Edinburgh.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 15/07/2026 | 78 443 ( 0,06 % ) | 7 M $ | 30/06/2026 |
Postes actifs de John Henderson
| Sociétés | Poste | Début |
|---|---|---|
| CYTOKINETICS, INCORPORATED | Président | 08/04/2022 |
Anciens postes connus de John Henderson
| Sociétés | Poste | Fin |
|---|---|---|
| MYRIAD GENETICS, INC. | Président | 23/03/2020 |
NeuroVia, Inc.
 NeuroVia, Inc. Pharmaceuticals: MajorHealth Technology Provides small molecule therapeutics for the treatment of neurologic disorders | Corporate Officer/Principal | 01/10/2018 |
| MYREXIS, INC. | Directeur/Membre du Conseil | 01/01/2013 |
Pfizer Pharmaceuticals, Inc.
 Pfizer Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Corporate Officer/Principal | 01/12/2000 |
| PFIZER INC. | Corporate Officer/Principal | 01/12/2000 |
Formation de John Henderson
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
50
Relations au 1er degré
10
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 10 |
|---|---|
Pfizer Inc.
 Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Myriad Genetics, Inc.
 Myriad Genetics, Inc. Medical SpecialtiesHealth Technology Develops therapeutic and predictive medicine products | Health Technology |
Inveresk Research Group, Inc.
 Inveresk Research Group, Inc. Miscellaneous Commercial ServicesCommercial Services Provides drug development services | Commercial Services |
Cytokinetics, Inc.
 Cytokinetics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that discovers, develops and commercializes novel drug products | Health Technology |
Myrexis, Inc.
 Myrexis, Inc. Financial ConglomeratesFinance Engages in identifying, evaluating and making financial investments in life sciences assets | Finance |
The University of Edinburgh
 The University of Edinburgh Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Asmacure Ltée
 Asmacure Ltée Pharmaceuticals: MajorHealth Technology Develops novel, proprietary compounds that target cholinergic receptors for the treatment of inflammation, notably pulmonary airway diseases | Health Technology |
Pfizer Pharmaceuticals, Inc.
Pfizer Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Futurepharm LLC | |
NeuroVia, Inc.
NeuroVia, Inc. Pharmaceuticals: MajorHealth Technology Provides small molecule therapeutics for the treatment of neurologic disorders | Health Technology |
